The way forward? Collaborate with robots

30 Oct 2019

Vetter increasingly relies on close interaction of humans and machines for greater flexibility.

Vetter's core competencies include the manufacturing of safe, user-friendly, complex packaging systems such as the assembly of pens, autoinjectors and safety devices. Thanks to the many years of experience and expert knowledge of its employees, the CDMO is able to meet the various requirements demanded of a drug product by regulatory authorities, customers and patients alike. To ensure customers' high-quality standards, while at the same time offering a high degree of flexibility, in the future the pharmaceutical service provider will increasingly focus on collaborative work. Following a successful pilot project, which included the use of a dual-arm robot in secondary packaging, the company is now planning the purchase of additional robots.

The way forward? Collaborate with robots
Collaborative work in secondary packaging. Picture source: Vetter Pharma International GmbH.

While large industrial robots work in restricted areas where humans are not permitted to enter during operation, collaborative robots provide close cooperation between humans and machines. In fact, at this year's Hanover Trade Fair, collaborative work was featured as one of the central topics. At Vetter, the collaborative dual-arm robot YuMi (You and Me) has been supporting automated secondary packaging processes since 2018. By inserting finished drug products and components into folding boxes, it performs an important task with a high degree of continuity and precision. Employees supply its work station with the required material and define its specific sequence of moves.

The acquisition of collaborative robots enables Vetter to meet the increasing demand for greater flexibility of its customers worldwide, and is playing an ever-greater role due to the growing diversity in packaging solutions and the trend towards smaller batches. "Fully automated systems allow fast throughput times and high quantities, but they lack flexibility due to long set-up times. This is exactly where our collaborative robot YuMi can make full use of its strengths," says Bernd Stauss, Senior Vice President Production and Engineering. Its high level of flexibility is based on a simple operating concept and excellent user-friendliness. These two qualities enable a wide range of deployment options and fast adaptation to changing product and packaging requirements.

With the first collaborative robot now having been successfully deployed in a pilot project lasting more than a year, the company will be acquiring two more models. The first model will be used to assemble a prefilled syringe barrel with plunger rod and finger flange. After its successful implementation in secondary packaging, the second model will be used for what is known as speed-bin-picking in aseptic production where prefilled syringes are placed into trays after terminal sterilization.

Read More

Related news

iNova Pharmaceuticals announces the launch of iPitch 2020

iNova Pharmaceuticals announces the launch of iPitch 2020

3 Jul 2020

Following on from the success of the inaugural iPitch launch in 2019, iNova Pharmaceuticals is delighted to announce the launch of a new round of iPitch challenges for 2020.

Read more 
Ajinomoto introduces fast track platform for drug product manufacturing

Ajinomoto introduces fast track platform for drug product manufacturing

30 Jun 2020

AJILITY is designed to speed novel or existing therapeutics from development to manufacturing and into the clinic.

Read more 
CPhI Worldwide to transform into Festival of Pharma digital experience

CPhI Worldwide to transform into Festival of Pharma digital experience

30 Jun 2020

The 10-day event will feature an interactive digital marketplace for sourcing products and services, enhanced matchmaking for connecting with new and existing partners, and world-renowned speakers.

Read more 
Catalent expands beauty and plant-based consumer health softgel capabilities

Catalent expands beauty and plant-based consumer health softgel capabilities

30 Jun 2020

Two company sites - one in Canada, the other in Brazil - receive new softgel encapsulation lines to service local customer demand.

Read more 
Stevanato Group pledges to provide glass vials for potential COVID-19 vaccines

Stevanato Group pledges to provide glass vials for potential COVID-19 vaccines

29 Jun 2020

The company agrees to provide CEPI with 100 million glass vials, which can store 20 doses per vial (2 billion doses in total).

Read more 
PCI Pharma Services completes biotech Center of Excellence

PCI Pharma Services completes biotech Center of Excellence

29 Jun 2020

The global outsourcing solutions provider is also set to expand its biotech capabilities in Europe.

Read more 
DuPont's seaweed-based soft capsule ingredient gains non-GMO certification

DuPont's seaweed-based soft capsule ingredient gains non-GMO certification

29 Jun 2020

SeaGel offers drug and dietary supplement manufacturers an animal-free and sustainable alternative to traditional soft capsules.

Read more 
Gilead pencils in potential buyout of Pionyr Immunotherapeutics

Gilead pencils in potential buyout of Pionyr Immunotherapeutics

23 Jun 2020

Pionyr's "promising, novel biology" could represent a major increase in Gileads's cancer pipeline.

Read more 
CordenPharma & Moderna extend lipid supply agreement for Moderna’s coronavirus vaccine

CordenPharma & Moderna extend lipid supply agreement for Moderna’s coronavirus vaccine

23 Jun 2020

The amended manufacturing agreement, which originally specified CordenPharma facilities Switzerland, now extends to the CDMOs France and US sites.

Read more 
TraceLink announces results from FDA DSCSA Pilot Program

TraceLink announces results from FDA DSCSA Pilot Program

23 Jun 2020

Key findings demonstrate the value of network solutions to secure and digitalize the pharmaceutical supply chain.

Read more